ACLS Provider: Course

Incorrect. Hypovolemia is a reversible cause of PEA and can be treated with rapid fluid resuscitation.

Incorrect. Adequate oxygenation and ventilation are critical to preventing hypoxia or hyperoxia after ROSC.

Incorrect. Adult defibrillation with a biphasic defibrillator typically starts at 120-200 J, not 360 J, depending on the manufacturer's guidelines.

Incorrect. First-line treatment to block vagal stimulation and increase heart rate.

Incorrect. Chest compressions should be paused for less than 10 seconds to minimize interruptions during CPR when delivering a shock.

Incorrect. Pediatric defibrillation begins at 2 J/kg and increases to 4 J/kg for subsequent shocks if needed.

Incorrect. Amiodarone is used after defibrillation and epinephrine for refractory VF to stabilize the myocardium.

Incorrect. Hypothermia is a potentially reversible cause of cardiac arrest and should be addressed during resuscitation.

Incorrect. IV access is preferred for rapid administration; IO is the alternative if IV access is unavailable.

Incorrect. A 15:2 ratio ensures optimal oxygenation and circulation during two-rescuer CPR in pediatric patients.

Incorrect. PEA is treated with CPR, epinephrine, and identifying reversible causes to restore organized electrical activity.

Incorrect. With an advanced airway in place, uninterrupted compressions improve blood flow while ventilation is delivered separately.

Incorrect. Switching every 2 minutes reduces rescuer fatigue and ensures high-quality chest compressions.

Incorrect. Magnesium sulfate stabilizes the myocardium and is the first-line treatment for torsades de pointes.

Incorrect. Amiodarone 300 mg IV/IO is administered after defibrillation and epinephrine to treat refractory VF or pulseless VT.

Incorrect. Atropine is the first-line drug for symptomatic bradycardia, increasing heart rate by blocking vagal stimulation.

Incorrect. Hypovolemia is a common reversible cause of PEA and should be addressed with rapid fluid resuscitation.

Incorrect. Ventricular fibrillation presents as a disorganized rhythm that requires immediate defibrillation.

Incorrect. With an advanced airway in place, compressions continue uninterrupted while breaths are delivered at 6-8 breaths per minute.

Incorrect. Epinephrine is the first-line drug for VF, with amiodarone as the preferred antiarrhythmic for refractory cases.

Incorrect. Magnesium sulfate is administered to stabilize the myocardium and terminate torsades de pointes.

Incorrect. Calcium gluconate stabilizes the cardiac membrane and reduces the risk of life-threatening arrhythmias caused by hyperkalemia.

Incorrect. The most reliable method to confirm and monitor placement by measuring exhaled CO?.

Incorrect. Epinephrine is dosed at 0.01 mg/kg IV/IO during pediatric cardiac arrest to improve coronary and cerebral perfusion.

Incorrect. A left lateral tilt prevents aortocaval compression, improving venous return and cardiac output during resuscitation.

Incorrect. Adenosine is used to terminate stable narrow-complex tachycardia by slowing AV node conduction.

Incorrect. The correct dose of epinephrine for pediatric cardiac arrest is 0.01 mg/kg IV/IO, not 1 mg/kg.

Incorrect. Epinephrine is repeated every 3-5 minutes during cardiac arrest to enhance perfusion pressure.

Incorrect. The jaw thrust maneuver opens the airway without moving the cervical spine, reducing the risk of spinal injury.

Incorrect. Pausing compressions for more than 10 seconds interrupts perfusion and reduces the chances of ROSC.

Incorrect. VF is a shockable rhythm, and defibrillation is the most effective intervention to restore a normal rhythm.

Incorrect. Post-ROSC care focuses on optimizing oxygenation, ventilation, and hemodynamic stability to prevent further organ damage.

Incorrect. For unstable narrow, irregular tachycardias, synchronized cardioversion at 120-200 J is recommended.

Incorrect. Epinephrine 1 mg IV/IO is administered every 3-5 minutes during cardiac arrest to improve coronary and cerebral perfusion.

Incorrect. Atrial flutter presents as a sawtooth pattern on the ECG and requires rate control or cardioversion depending on stability.

Incorrect. A rate of 100-120 compressions per minute ensures adequate circulation in pediatric patients.

Incorrect. TTM helps reduce neurological injury by maintaining a core temperature of 32-36°C after the return of spontaneous circulation.

Incorrect. The jaw thrust technique opens the airway while minimizing cervical spine movement, reducing the risk of further injury.

Incorrect. Adenosine is administered as a rapid IV push to terminate SVT in pediatric patients, followed by a saline flush.

Incorrect. High-quality CPR should be resumed immediately after defibrillation to maintain perfusion and increase chances of ROSC.

Incorrect. Needle decompression relieves pressure caused by tension pneumothorax, improving ventilation and circulation.

Incorrect. Pediatric defibrillation starts at 2 J/kg for the initial shock, increasing as needed based on the patient's response.

Incorrect. Calling for help ensures timely assistance and access to advanced resuscitation equipment.

Incorrect. Magnesium sulfate is used to treat torsades de pointes but is not the first-line drug for VF, where epinephrine is prioritized.

Incorrect. Activating EMS ensures help is on the way while you assess and initiate resuscitation.

Incorrect. Administered every 3-5 minutes to restore circulation by increasing coronary and cerebral perfusion pressure.

Incorrect. Two minutes of CPR (about 5 cycles of 30 compressions and 2 breaths) should be completed before checking the rhythm.

Incorrect. Adenosine is administered as a 6 mg rapid IV push, followed by a saline flush, to terminate reentrant arrhythmias.

Incorrect. Amiodarone is administered as a 300 mg IV/IO bolus for refractory VF or pulseless VT.

Incorrect. Adenosine is the first-line drug for treating narrow-complex SVT by slowing conduction through the AV node.

Incorrect. CPR is the primary intervention for PEA, followed by epinephrine and identification of reversible causes.

Incorrect. PEA is treated with CPR and epinephrine, as defibrillation is ineffective for non-shockable rhythms.

Incorrect. Amiodarone is used to stabilize wide-complex tachycardias in stable patients to prevent deterioration into cardiac arrest.

Incorrect. ROSC stands for "Return of Spontaneous Circulation," indicating the resumption of a perfusing rhythm.

Incorrect. PEA is not treated with adenosine; it is managed with CPR, epinephrine, and identifying and treating reversible causes.

Incorrect. Hypovolemia is a reversible cause of cardiac arrest that can be treated with fluid resuscitation to restore circulation.

Incorrect. Delivering 6-8 breaths per minute ensures adequate oxygenation without hyperventilation during CPR with an advanced airway.

Incorrect. The jaw-thrust avoids neck movement, making it the preferred airway technique for patients with suspected cervical spine injuries.

Incorrect. Atropine at 0.5 mg IV is the first-line treatment for symptomatic bradycardia caused by vagal stimulation.

Incorrect. Rhythm checks are performed every 2 minutes to evaluate for shockable rhythms and assess the effectiveness of interventions.

Incorrect. Adenosine is administered as a rapid IV push at an initial dose of 6 mg to terminate stable SVT.

Incorrect. Adenosine is the first-line drug for stable SVT, while synchronized cardioversion is used for unstable SVT.

Incorrect. High-quality CPR is the primary treatment for asystole, along with epinephrine and addressing reversible causes.

Incorrect. Synchronized cardioversion with 120-200 J is used to restore normal rhythm in unstable atrial fibrillation.

Incorrect. Hypothermia is a reversible cause of cardiac arrest and must be corrected to restore spontaneous circulation.